Ben Ho Park, MD, PHD - Publications

Genetics Johns Hopkins University, Baltimore, MD 

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hunter N, Croessmann S, Cravero K, Shinn D, Hurley PJ, Park BH. Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 375-379. PMID 32259780 DOI: 10.6004/jnccn.2019.7381  0.36
2019 Kyker-Snowman K, Hughes RM, Yankaskas CL, Cravero K, Karthikeyan S, Button B, Waters I, Rosen DM, Dennison L, Hunter N, Donaldson J, Christenson ES, Konstantopoulos K, Hurley PJ, Croessmann S, ... Park BH, et al. TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties. Breast Cancer Research and Treatment. PMID 31823098 DOI: 10.1007/S10549-019-05506-3  0.36
2019 Dalton WB, Helmenstine E, Walsh N, Gondek LP, Kelkar DS, Read A, Natrajan R, Christenson ES, Roman B, Das S, Zhao L, Leone RD, Shinn D, Groginski T, Madugundu AK, ... ... Park B, et al. Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. The Journal of Clinical Investigation. 130. PMID 31393856 DOI: 10.1172/Jci125022  0.6
2019 Torquato S, Pallavajjala A, Goldstein A, Toro PV, Silberstein JL, Lee J, Nakazawa M, Waters I, Chu D, Shinn D, Groginski T, Hughes RM, Simons BW, Khan H, Feng Z, ... ... Park BH, et al. Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer. Jco Precision Oncology. 3. PMID 31131348 DOI: 10.1200/PO.18.00227  0.36
2018 Cravero K, Medford A, Pallavajjala A, Canzoniero J, Hunter N, Chu D, Cochran RL, Waters I, Christenson ES, Kyker-Snowman K, Button B, Cole AJ, Park BH. Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity. Practical Laboratory Medicine. 12: e00108. PMID 30140723 DOI: 10.1016/j.plabm.2018.e00108  0.36
2018 Alhuqail AJ, Alzahrani A, Almubarak H, Al-Qadheeb S, Alghofaili L, Almoghrabi N, Alhussaini H, Park BH, Colak D, Karakas B. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients. Breast Cancer Research and Treatment. PMID 29297111 DOI: 10.1007/S10549-017-4635-4  0.56
2017 Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, ... ... Park BH, et al. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. Jco Precision Oncology. 2017. PMID 30003184 DOI: 10.1200/PO.16.00046  0.6
2017 Avigdor B, Beierl K, Gocke CD, Zabransky D, Cravero K, Kyker-Snowman K, Button B, Chu D, Croessmann S, Cochran RL, Connolly R, Park BH, Cimino-Mathews A, Wheelan SJ. Whole exome sequencing of metaplastic breast carcinoma indicates monoclonality with associated ductal carcinoma component. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28424200 DOI: 10.1158/1078-0432.Ccr-17-0108  0.36
2017 Croessmann S, Wong HY, Zabransky DJ, Chu D, Rosen DM, Cidado J, Cochran RL, Dalton WB, Erlanger B, Cravero K, Button B, Kyker-Snowman K, Hurley PJ, Lauring J, Park BH. PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity. Breast Cancer Research and Treatment. PMID 28190247 DOI: 10.1007/s10549-017-4147-2  0.6
2017 Goldstein A, Valda Toro P, Lee J, Silberstein JL, Nakazawa M, Waters I, Cravero K, Chu D, Cochran RL, Kim M, Shinn D, Torquato S, Hughes RM, Pallavajjala A, Carducci MA, ... Park BH, et al. Detection fidelity of AR mutations in plasma derived cell-free DNA. Oncotarget. PMID 28152506 DOI: 10.18632/Oncotarget.14926  0.36
2016 Lee J, Axilbund J, Dalton WB, Laheru D, Watkins S, Chu D, Cravero K, Button B, Kyker-Snowman K, Waters I, Gocke CD, Lauring J, Park BH. A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 1495-1498. PMID 27956534 DOI: 10.6004/JNCCN.2016.0161  0.6
2016 Parsons HA, Beaver JA, Cimino-Mathews A, Ali SM, Axilbund J, Chu D, Connolly R, Cochran R, Croessmann S, Clark T, Gocke CD, Jeter SC, Kennedy M, Lauring J, Lee J, ... ... Park BH, et al. Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27489289 DOI: 10.1158/1078-0432.CCR-16-1543  0.6
2016 Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, Zabransky DJ, Mohseni M, Beaver JA, Chu D, Cravero K, ... ... Park BH, et al. Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget. PMID 26823390 DOI: 10.18632/oncotarget.7057  0.36
2015 Wong HY, Wang GM, Croessmann S, Zabransky DJ, Chu D, Garay JP, Cidado J, Cochran RL, Beaver JA, Aggarwal A, Liu ML, Argani P, Meeker A, Hurley PJ, Lauring J, ... Park BH, et al. TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer. Oncotarget. PMID 26702755 DOI: 10.18632/Oncotarget.6743  0.36
2015 Zabransky DJ, Yankaskas CL, Cochran RL, Wong HY, Croessmann S, Chu D, Kavuri SM, Red Brewer M, Rosen DM, Dalton WB, Cimino-Mathews A, Cravero K, Button B, Kyker-Snowman K, Cidado J, ... ... Park BH, et al. HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proceedings of the National Academy of Sciences of the United States of America. PMID 26508629 DOI: 10.1073/Pnas.1516853112  0.6
2015 Hurley PJ, Sundi D, Shinder B, Simons B, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing CM, ... ... Park BH, et al. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment and are Differentially Associated with Metastatic Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26446945 DOI: 10.1158/1078-0432.Ccr-15-0256  0.36
2015 Chu D, Paoletti C, Gersch C, VanDenBerg D, Zabransky D, Cochran R, Wong HY, Valda Toro P, Cidado J, Croessmann S, Erlanger B, Cravero K, Kyker-Snowman K, Button B, Parsons H, ... ... Park BH, et al. ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26261103 DOI: 10.1158/1078-0432.CCR-15-0943  0.6
2012 Garay JP, Park BH. Androgen receptor as a targeted therapy for breast cancer. American Journal of Cancer Research. 2: 434-45. PMID 22860233  0.92
2009 Higgins MJ, Abukhdeir AM, Gustin J, Vitolo MI, Bachman KE, Park BH. Preclinical study of lithium sensitivity in human breast PTEN knock out cell lines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e14641. PMID 27964232 DOI: 10.1200/Jco.2009.27.15_Suppl.E14641  0.56
2008 Gustin JP, Cosgrove DP, Park BH. The PIK3CA gene as a mutated target for cancer therapy. Current Cancer Drug Targets. 8: 733-40. PMID 19075596  0.68
2008 Lauring J, Abukhdeir AM, Konishi H, Garay JP, Gustin JP, Wang Q, Arceci RJ, Matsui W, Park BH. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood. 111: 856-64. PMID 17942756 DOI: 10.1182/blood-2007-05-088674  0.92
2007 Konishi H, Lauring J, Garay JP, Karakas B, Abukhdeir AM, Gustin JP, Konishi Y, Park BH. A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting. Nature Protocols. 2: 2865-74. PMID 18007621 DOI: 10.1038/nprot.2007.409  0.92
2007 Konishi H, Karakas B, Abukhdeir AM, Lauring J, Gustin JP, Garay JP, Konishi Y, Gallmeier E, Bachman KE, Park BH. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation. Cancer Research. 67: 8460-7. PMID 17875684 DOI: 10.1158/0008-5472.CAN-07-0108  0.92
2004 Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biology & Therapy. 3: 772-5. PMID 15254419  0.56
2004 Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S, Hicks J, De Marzo AM, Argani P, Park BH. p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biology & Therapy. 3: 221-5. PMID 14726675  0.36
Show low-probability matches.